We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Non-Insulin Diabetes Drugs Mask Surgical Ketoacidosis

By HospiMedica International staff writers
Posted on 31 Jul 2019
A new study warns that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can lead to dangerous undetected ketoacidosis in diabetics during surgery, as their blood sugar level remains normal.

Researchers at Queen Elizabeth Hospital (Adelaide, Australia) and the University of Adelaide (UA; Australia) searched PubMed, Embase, and ProQuest for clinical reports of perioperative diabetic ketoacidosis (DKA) with near-normal blood glucose concentrations, termed euglycaemic ketoacidosis (EDKA), involving SGLT2i medications up to January 2019. More...
In all, 42 cases of EDKA and five cases of hyperglycaemic diabetic ketoacidosis (HDKA) were reported.

The SGLT2i Canagliflozin was implicated in 26 cases, with presentation time varying from a few hours up to six weeks after surgery. Precipitating factors included medication changes, diet modifications, and intercurrent illnesses. Thirteen of the cases (12 EDKA, one HDKA) involved bariatric surgery, with 10 of these patients noted very-low-calorie diet regimes as a precipitating factor. Seven patients required mechanical ventilation, and acute kidney injury (AKI) was noted in five. Outcome data were available in 32 cases, all of them recovered completely. The study was published in the July 2019 issue of the British Journal of Anaesthesia.

“Euglycaemic ketoacidosis can happen in people with both type 1 and type 2 diabetes. Unless special tests are done to assess the acid load in the body, clinicians can miss this complication. The symptoms are similar to other events during and after surgery such as mild acid build up, vomiting, and abdominal pain,” said lead author Venkatesan Thiru, MD. “Euglycaemic ketoacidosis is deceiving and likely to be missed easily as it presents with near or low-normal blood sugars.”

“Gliflozin medications are being increasingly used to protect people against heart and kidneys diseases. They work in the kidneys to excrete excess sugar in diabetic patients’ urine. The condition may happen in the lead-up to surgery when patients cannot eat and drink normally,” concluded Dr. Thiru. “Patients who undertake weight reduction surgery when they are on a special diet program are at an increased risk of experiencing this complication. Extra vigilance is the key, and patients should be educated about this. Caregivers should ask for acid load to be tested by checking for blood ketone levels.”

DKA arises because of a lack of insulin in the body, which leads to an increased release of glucose by the liver via glycogenolysis and gluconeogenesis. The high glucose levels spill over into the urine, taking water and minerals along with it, in a process known as osmotic diuresis. This leads to the release of free fatty acids from adipose tissue, which are converted through beta oxidation into ketone bodies. The ketone bodies, in turn, cause the blood to turn acidic (metabolic acidosis), which can lead to serious consequences, including coma and death.

Related Links:
Queen Elizabeth Hospital
University of Adelaide


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.